Literature DB >> 18434429

C2C12 myoblastoma cell differentiation and proliferation is stimulated by androgens and associated with a modulation of myostatin and Pax7 expression.

P Diel1, D Baadners, K Schlüpmann, M Velders, J P Schwarz.   

Abstract

Androgens are modulators of skeletal muscle adaptation and regeneration processes. The control of satellite cell activity is a key mechanism during this process. In this study, we analyzed the ability of dihydrotestosterone (DHT) and anabolic steroids to induce and modulate the differentiation of C2C12 myoblastoma cells toward myotubes. C2C12 cells were dose-dependently treated with DHT and anabolic steroids. The time-dependent effects on differentiation were measured and correlated with the expression of genes involved in the regulation of satellite cell activity. The distribution of C2C12 cells within the cell cycle was measured by flow cytometry and differentiation by creatine kinase (CK) activity. Gene expression was analyzed using quantitative real-time PCR and confocal microscopy. The treatment with DHT and anabolic steroids resulted in a stimulation of C2C12 cell proliferation and CK activity. The antiandrogen flutamide was able to antagonize this effect. The expression of the androgen receptor, SOX8, SOX9, Delta, Notch, myostatin, and paired box gene7 (Pax7) was modulated by androgens. The treatment with DHT and anabolic steroids resulted in a strong stimulation of myostatin expression not only in undifferentiated cells but also in myotubes. The stimulation could be antagonized by flutamide. The expression of Pax7 was detectable in C2C12 cells early after treatment with DHT. Our results demonstrate that the key mechanisms of satellite cell differentiation are modulated by androgens. Androgens stimulate the proliferation of C2C12 cells, accelerate the process of differentiation, and increase the expression of myostatin in undifferentiated and differentiated cells. Our findings may have implications not only for the treatment of muscular diseases but also for the improvement of doping analytical methods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434429     DOI: 10.1677/JME-07-0175

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  21 in total

Review 1.  Androgens and skeletal muscle: cellular and molecular action mechanisms underlying the anabolic actions.

Authors:  Vanessa Dubois; Michaël Laurent; Steven Boonen; Dirk Vanderschueren; Frank Claessens
Journal:  Cell Mol Life Sci       Date:  2011-11-19       Impact factor: 9.261

2.  Goodpasture antigen-binding protein (GPBP) directs myofibril formation: identification of intracellular downstream effector 130-kDa GPBP-interacting protein (GIP130).

Authors:  Francisco Revert-Ros; Ernesto López-Pascual; Froilán Granero-Moltó; Jesús Macías; Richard Breyer; Roy Zent; Billy G Hudson; Anas Saadeddin; Fernando Revert; Raül Blasco; Carmen Navarro; Deborah Burks; Juan Saus
Journal:  J Biol Chem       Date:  2011-08-09       Impact factor: 5.157

3.  A novel adipokine C1q/TNF-related protein 3 is expressed in developing skeletal muscle and controls myoblast proliferation and differentiation.

Authors:  Masataka Otani; Souhei Furukawa; Satoshi Wakisaka; Takashi Maeda
Journal:  Mol Cell Biochem       Date:  2015-08-14       Impact factor: 3.396

4.  Assessment of reference genes for real-time quantitative PCR gene expression normalization during C2C12 and H9c2 skeletal muscle differentiation.

Authors:  Twinkle J Masilamani; Julie J Loiselle; Leslie C Sutherland
Journal:  Mol Biotechnol       Date:  2014-04       Impact factor: 2.695

5.  Research Resource: The androgen receptor modulates expression of genes with critical roles in muscle development and function.

Authors:  Anastasia Wyce; Yuchen Bai; Sunil Nagpal; Catherine C Thompson
Journal:  Mol Endocrinol       Date:  2010-07-07

6.  Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development.

Authors:  Ryan L Sheppard; Espen E Spangenburg; Eva R Chin; Stephen M Roth
Journal:  Physiol Genomics       Date:  2011-08-09       Impact factor: 3.107

7.  The role of GH and IGF-I in mediating anabolic effects of testosterone on androgen-responsive muscle.

Authors:  Carlo Serra; Shalender Bhasin; Frances Tangherlini; Elisabeth R Barton; Michelle Ganno; Anqi Zhang; Janet Shansky; Herman H Vandenburgh; Thomas G Travison; Ravi Jasuja; Carl Morris
Journal:  Endocrinology       Date:  2010-11-17       Impact factor: 4.736

8.  Nonmyocytic androgen receptor regulates the sexually dimorphic development of the embryonic bulbocavernosus muscle.

Authors:  Lerrie Ann Ipulan; Kentaro Suzuki; Yuki Sakamoto; Aki Murashima; Yuuki Imai; Akiko Omori; Naomi Nakagata; Ryuichi Nishinakamura; Petr Valasek; Gen Yamada
Journal:  Endocrinology       Date:  2014-04-17       Impact factor: 4.736

9.  Signaling pathways implicated in androgen regulation of endocortical bone.

Authors:  Kristine M Wiren; Anthony A Semirale; Joel G Hashimoto; Xiao-Wei Zhang
Journal:  Bone       Date:  2009-11-04       Impact factor: 4.398

10.  Change in Nox4 expression is accompanied by changes in myogenic marker expression in differentiating C2C12 myoblasts.

Authors:  S Acharya; A M Peters; A S Norton; G K Murdoch; R A Hill
Journal:  Pflugers Arch       Date:  2013-03-16       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.